| Application no. and date | 03783422.3 (espacenet) (Federated) (European Patent Register), 20031113 | | Patent/reg. no. and date | DK/EP 1567152, 20130814 | | Publication date | 20050831 | | Priority no. and date | US 426543 P, 20021115 | | EP pub. no. and date |
EP 1567152 20050831 | | Effective date | | | Applicant/owner | Teva Pharmaceutical Industries Limited, 5 Basel Street,
Box 3190
Petah Tikvah 49131, IL | | Applicant ref. no. | p52643dk01 | | Inventor | BLAUGRUND, Eran, 94 Remez St.
76449 Rehovot, IL,
LEVY, Ruth, 25 Sasha Argov street,
Apt. 2
69620 Tel-Aviv, IL | | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup | | Opponent | | | IPC Class | A61K 31/135 (2006.01) , A61K 31/425 (2006.01) , A61K 31/428 (2006.01) , A61P 25/28 (2006.01) | | Title | ANVENDELSE AF RASAGILIN MED RILUZOL TIL BEHANDLING AF AMYOTROPH LATERAL SKLEROSE | | Int. application no. | US2003036288 | | Int. publication no. | WO2004045515 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
